614 filings
Page 3 of 31
D
NBSE
NeuBase Therapeutics Inc
7 Jul 23
Exempt offering of security
4:11pm
8-K
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
NBSE
NeuBase Therapeutics Inc
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B3
NBSE
NeuBase Therapeutics Inc
30 Jun 23
Prospectus supplement
8:41am
8-K
NBSE
NeuBase Therapeutics Inc
14 Jun 23
NeuBase Announces 1-for-20 Reverse Stock Split
4:10pm
10-QT
NBSE
NeuBase Therapeutics Inc
5 Jun 23
Quarterly report for transitional period
4:05pm
8-K
NBSE
NeuBase Therapeutics Inc
22 May 23
Regulation FD Disclosure
7:00am
8-K
NBSE
NeuBase Therapeutics Inc
18 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
NBSE
NeuBase Therapeutics Inc
11 May 23
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
4:20pm
10-Q
2023 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
11 May 23
4:05pm
8-K
NBSE
NeuBase Therapeutics Inc
24 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
NBSE
NeuBase Therapeutics Inc
29 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm
UPLOAD
NBSE
NeuBase Therapeutics Inc
20 Mar 23
Letter from SEC
12:00am
4
Todd P. Branning
17 Mar 23
NeuBase Therapeutics / Todd P. Branning ownership change
4:11pm
4
Stephan Dietrich A
17 Mar 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:11pm
CORRESP
NBSE
NeuBase Therapeutics Inc
16 Mar 23
Correspondence with SEC
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
8 Mar 23
Letter from SEC
12:00am
S-8
NBSE
NeuBase Therapeutics Inc
6 Mar 23
Registration of securities for employees
4:22pm
4
NBSE
NeuBase Therapeutics Inc
15 Feb 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
7:30pm
8-K
NBSE
NeuBase Therapeutics Inc
14 Feb 23
NeuBase Therapeutics Reports Business Update and Financial Results
4:20pm